news
Parkinson’s disease drug carbidopa shows anticancer effects
Research shows the Parkinson's disease drug carbidopa displays significant anticancer effects in human cell lines...
List view / Grid view
Formulation
news
FDA approves Verzenio for metastatic breast cancer
The FDA has approved Verzenio to treat advanced or metastatic breast cancer that has progressed after taking therapy...
news
EC grants marketing authorisation of Dupixent for atopic dermatitis
Sanofi and Regeneron Pharmaceuticals, Inc. have announced that the EC has granted marketing authorisation for Dupixent for use in adults with moderate-to-severe atopic dermatitis...
news
Ivermectin found to suppresses tumour development
Researchers find ivermectin, a drug used to kill parasites, suppresses tumour development in epithelial ovarian cancer...
news
Vaccine demonstrates significant efficacy against severe rotavirus
Results from a Phase 3 efficacy study in India of the rotavirus vaccine Rotasil showed the vaccine to be safe, against severe rotavirus gastroenteritis...
news
UCB receives EU approval for paediatric anti-epileptic drug
UCB has announced that the EC has approved the use of its anti-epileptic drug Vimpatas in the treatment of partial-onset seizures...
news
TLR agonists suppress tumour growth
TLR agonists injected directly into a tumour suppresses tumour growth throughout the whole body...
news
Romosozumab provides protection against fractures in osteoporosis
A new treatment for osteoporosis provides major improvements in bone density and fractures than the current standard treatment...
news
Poliovirus therapy induces immune responses against cancer
Investigational therapy directly kills tumour cells and unmasks them to the body's defences.
news
HPV vaccine associated with improved fertility
Researchers have examined the relationship between the HPV vaccination and fertility and identified that the vaccine can improve chances of conception...
news
ALA-artemisinin combination therapy for cancer identified
Artemisinin, a potent anti-malarial drug, has been widely hailed as a promising alternative cancer treatment...
news
FDA approves first biosimilar for the treatment of cancer
Mvasi, a biosimilar to the cancer drug Avastin, is approved for certain colorectal, lung, brain, kidney and cervical cancers…
news
FDA-approved drug may block resistance to anti-angiogenesis therapy
General study identifies targetable pathway that induces immunosuppressive environment in colorectal cancer...
news
Type 2 diabetes drug provides significant benefits to type 1 diabetic patients
A study has found that a majority of patients with Type 1 diabetes who were treated with dapagliflozin, a Type 2 diabetes medicine, had a significant decline in their blood sugar levels...
news
Nivolumab superior to ipilimumab for adjuvant treatment of melanoma
Adjuvant nivolumab has been found to be more superior than ipilimumab in the standard of care in patients with surgically resected stage III/IV melanoma...
